In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they plan to reclassify cannabis being a Timetable III drug. This rescheduling will realize that cannabis has legitimate healthcare reasons and may help open up the door to research on other likely remedy takes advantage of. CB